GQ Asset Management’s Amedisys AMED Stock Holding History

GQ Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-885	Closed	-$109K	–	136
2019 Q1	$109K	Buy	+885	New	+$111K	0.07%	100

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

GQ Asset Management's AMED Position: Q2 2019 in Review

GQ Asset Management sold out of Amedisys (AMED) in Q2 2019, closing a stake of 885 shares — an estimated $109K sold.

GQ Asset Management first reported a position in AMED in Q1 2019 and held it in 1 quarter. The position peaked at $109K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

GQ Asset Management reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
GQ Asset Management sold 885 Amedisys shares in Q2 2019, an estimated $109K.
GQ Asset Management first reported a position in Amedisys in Q1 2019 and held it in 1 quarter.
GQ Asset Management's Amedisys position peaked at $109K in Q1 2019.
285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on GQ Asset Management's 13F filing for Q2 2019, filed 13 Aug 2019.